Find policies, billing codes, payers, states, and providers
Bariatric Surgery
Customize your policy alerts
Sign up for Premera Bluecross Policy 7.01.516 alerts
Get alerted when Policy 7.01.516 changes without checking for updates manually.
Monitor payer policy activity
Policy governing medical necessity, coverage criteria, documentation, and coding guidance for bariatric (weight loss) surgical procedures for Premera Bluecross members.
No material clinical or coverage changes in this revision.
Coverage Criteria and Medical Necessity
Primary coverage for adults with class II/III obesity
Covered when ALL of the following criteria are met:
BMI criteria
- Comorbid examples: Established coronary heart disease (history of angina, angioplasty, coronary artery surgery, or myocardial infarction), other atherosclerotic disease (e.g., AAA, peripheral arterial disease), uncontrolled or medically refractory hypertension (despite ≥2 medications of different classes), type 2 diabetes that is uncontrolled (HbA1c ≥7), moderate to severe obstructive sleep apnea after failure of CPAP/BiPAP/oral applianceHbA1c ≥7 for diabetes
OSA failure defined elsewhere
Structured commercial programs acceptable if supervised by a provider
Adults with T2 diabetes and class I obesity
Covered when ALL of the following are met:
A surgeon summary letter alone is not sufficient
Revision, conversion, and reoperation criteria
Revision or conversion may be covered for complications or inadequate weight loss when specific criteria are met.
May be billed with unlisted CPT 43659 for some procedures
Inadequate weight loss due to individual noncompliance is not medically necessary indication for revision
General Medical Necessity and Preoperative Requirements
Covered when ALL of the following are met:
Some centers require documented supervised programs
Procedure Selection Considerations
Selection considerations and documented indications:
Adolescent-specific Criteria
Adolescents considered for bariatric surgery should meet ALL relevant items:
See society guidance for specific pediatric thresholds
Multidisciplinary evaluation recommended; device labelling may restrict use in <18 yrs
Preoperative and procedural clinical criteria
Clinical principles and preoperative expectations referenced in this section:
See Background and documentation requirements
Fundoplication may be beneficial when repairing type II–IV hernias
ASMBS 2021 and AGA 2024 guidance referenced
Class III obesity (BMI ≥40 kg/m2)
Adults with Class III obesity
Supported by RCTs, observational studies, and systematic reviews
Class II obesity (BMI 35–39.9 kg/m2)
Adults with Class II obesity
Evidence includes RCTs, observational studies, and systematic reviews
Class I obesity (BMI 30–34.9 kg/m2) with T2D
Adults with Class I obesity and type 2 diabetes
Quality of evidence graded low to very low; balance benefits vs short-term surgical risks
Lower-BMI adults without T2D
Adults with BMI <35 kg/m2 without T2D
Small RCTs and case series exist but long-term net benefit unclear
Revision procedures
Revision bariatric surgery
Evidence indicates revision procedures can be safe and efficacious
Adolescents
Adolescents with obesity
Most guidelines reserve surgery for severe comorbidities or very high BMI and recommend multidisciplinary evaluation
Preadolescent children
Preadolescent children
Further comparative studies required
Hiatal hernia repair during bariatric surgery
Hiatal hernia repair with bariatric surgery
No evidence to support repair for incidental intraoperative findings
Preoperative EGD
Esophagogastroduodenoscopy (EGD) with bariatric surgery
Comparative evidence on routine vs selective EGD is insufficient; use AGA/ASMBS guidance for high-quality endoscopy
Pediatric/adolescent coverage indications (society summaries)
Adolescent/pediatric criteria (society summaries):
AAP and ASMBS recommend referral for adolescents ≥13 years meeting severe obesity criteria
Adolescent metabolic/bariatric surgery criteria (ASMBS/Endocrine Society)
Professional society guidance (ASMBS and Endocrine Society) regarding adolescent indications and considerations:
ASMBS 2022 statement
ASMBS guidance
Endocrine Society (2008, updated 2017)
EGD preoperative and surveillance criteria (ASMBS and gastroenterology societies)
ASMBS and gastroenterology society statements on upper GI endoscopy before and after bariatric surgery:
ASMBS 2021 position statement
ASMBS recommendation pending longer-term studies
AGA 2024 practice update
The policy lists several bariatric procedures that are considered investigational and are excluded from favorable coverage conclusions. Examples include biliopancreatic diversion or bypass without duodenal switch, Billroth II / single-anastomosis (mini) gastric bypass, laparoscopic gastric plication (LGCP), long-limb gastric bypass (>150 cm), two-stage procedures, vagal nerve blocking (VBLOC/Maestro), and a range of endoscopic primary or revision procedures such as endoscopic sleeve gastroplasty (ESG), intragastric balloons (e.g., ORBERA, Obalon, Spatz3), restorative obesity surgery endoluminal (ROSE), transoral outlet reduction (TORe), aspiration devices (e.g., AspireAssist), natural orifice transluminal endoscopic surgery (NOTES), and duodenal-jejunal sleeves (endoscopic gastrointestinal liners).
A documented mental health evaluation and clearance by a licensed mental health provider is required to rule out contraindicating psychiatric disorders and inability to comply with perioperative requirements; the policy explicitly states that a letter from a healthcare provider alone is insufficient to meet this requirement.
Guidance on hiatal hernia repair notes that repair of a type I (sliding) hiatal hernia in the absence of reflux disease is not necessary. Symptomatic paraesophageal (type II–IV) hernias should be repaired, and fundoplication may be considered when repairing type II–IV hernias, but incidental sliding hernia without reflux does not by itself indicate repair.
The evidence is insufficient to conclude that bariatric surgery provides a long-term net health benefit for adults with BMI <35 kg/m2 who do not have type 2 diabetes, and the policy states that preadolescent children lack focused studies demonstrating net benefit; thus these populations are not supported for routine surgical coverage based on current evidence.
The policy summarizes explicitly listed contraindications drawn from professional guidance, including medically correctable causes of obesity, untreated or poorly controlled substance abuse, concurrent or planned pregnancy, current eating disorder, and inability to adhere to postoperative recommendations and mandatory lifestyle changes.
The Medicare National Coverage Determination (NCD) from 2006 is summarized: it considers RYGB, LAGB, and BPD/DS reasonable and necessary for Medicare beneficiaries with BMI >35 kg/m2 plus comorbidity, and it lists as noncovered the following procedures for all Medicare beneficiaries: open vertical-banded gastroplasty, laparoscopic vertical-banded gastroplasty, open sleeve gastrectomy, laparoscopic sleeve gastrectomy, and open adjustable gastric banding.
The references section compiles guideline and evidence citations but does not specify additional explicit coverage exclusions beyond those articulated elsewhere in the policy.
The policy document states that it does not apply to Medicare Advantage and that coverage decisions remain subject to each member's benefit plan limits and conditions.
The policy specifies that bariatric surgery is considered not medically necessary for individuals with BMI <35 kg/m2 who do not have T2D, and for all individuals with BMI <30 kg/m2 (except where Asian-specific exceptions apply). This general exclusion is reiterated and tied to the insufficiency of long-term evidence in lower-BMI adults without T2D.
The policy states that routine liver biopsy during obesity surgery is not medically necessary in the absence of preoperative signs or symptoms of liver disease (for example, elevated liver enzymes or hepatomegaly).
The policy clarifies that revision or conversion surgery is not considered medically necessary when the only reason is inadequate weight loss due to the individual's noncompliance with postoperative nutrition and exercise recommendations.
Vertical-banded gastroplasty (VBG; CPT 43842) is described as a procedure that is largely no longer performed in the U.S. because of high rates of complications and reoperations; it is not included on the ASMBS list of endorsed procedures and is therefore not an endorsed option in contemporary practice.
For adults with BMI <35 kg/m2 who do not have type 2 diabetes, the policy concludes the evidence is insufficient to establish long-term benefit of bariatric procedures; consequently such procedures are not supported as medically necessary in this population.
The Endocrine Society advises against bariatric surgery for preadolescent children and recommends caution for pregnant or breastfeeding adolescents and those planning pregnancy within two years of surgery. Professional society guidance emphasizes Tanner stage, near-final height, psychosocial readiness, and avoidance of surgery in patients with unresolved substance abuse or eating disorders.
The references section catalogs randomized trials, systematic reviews, and guideline documents used to support the policy recommendations; this compendium of evidence does not itself list additional not-medically-necessary conditions beyond those specified in the policy text.
Coding and Reimbursement
| 43845 | Biliopancreatic bypass with duodenal switch (open) |
| 43659 | Unlisted laparoscopic procedure, used here for duodenal switch (lap) per policy |
| 43644 | Laparoscopic Roux-en-Y gastric bypass |
| 43645 | Open Roux-en-Y gastric bypass |
| 43846 | Roux-en-Y gastroenterostomy (short limb ≤150 cm) |
| 43770 | Laparoscopic adjustable gastric banding |
| 43775 | Sleeve gastrectomy |
| 43999 | Unlisted procedure, stomach (used for SADI-S per policy) |
| 43847 | Long-limb gastric bypass procedure (>150 cm) — investigational |
| 43842 | Vertical-banded gastroplasty (VBG) — not medically necessary |
| 43843 | Laparoscopic gastric plication (LGCP) — investigational |
| 43889 | Endoscopic sleeve gastroplasty (ESG) — investigational |
| 0813T | Spatz3 intragastric balloon (listed as example) — investigational |
| C9785 | Transoral outlet reduction (TORe) HCPCS — investigational |
| 0813T | Esophagogastroduodenoscopy, flexible, transoral, with volume adjustment of intragastric bariatric balloon (e.g., Spatz3). |
| 43290 | Esophagogastroduodenoscopy, flexible, transoral; with deployment of intragastric bariatric balloon. |
| 43291 | Esophagogastroduodenoscopy, flexible, transoral; with removal of intragastric bariatric balloon(s). |
| 43644 | Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and Roux-en-Y gastroenterostomy (roux limb 150 cm or less). |
| 43645 | Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and small intestine reconstruction to limit absorption |
| 43659 | Unlisted laparoscopy procedure, stomach / Laparoscopy, surgical, gastric restrictive procedure; placement of adjustable gastric restrictive device (eg, gastric band and subcutaneous port components). |
| 43772 | Laparoscopy, surgical, gastric restrictive procedure; removal of adjustable gastric restrictive device component only. |
| 43773 | Laparoscopy, surgical, gastric restrictive procedure; removal and replacement of adjustable gastric restrictive device component only. |
| 43774 | Laparoscopy, surgical, gastric restrictive procedure; removal of adjustable gastric restrictive device and subcutaneous port components. |
| 43775 | Laparoscopy, surgical, gastric restrictive procedure; longitudinal gastrectomy (i.e., sleeve gastrectomy). |
| 43842 | Gastric restrictive procedure, without gastric bypass, for morbid obesity; vertical-banded gastroplasty. |
| 43843 | Gastric restrictive procedure, without gastric bypass, for morbid obesity; other than vertical-banded gastroplasty. |
| 43845 | Gastric restrictive procedure with partial gastrectomy, pylorus-preserving duodenoileostomy and ileoileostomy (50 to 100 cm common channel) to limit absorption (biliopancreatic diversion with duodenal switch). |
| 43846 | Gastric restrictive procedure, with gastric bypass for morbid obesity; with short limb (150 cm or less) Roux-en-Y gastroenterostomy. |
| 43847 | Gastric restrictive procedure, with gastric bypass for morbid obesity; with small intestine reconstruction to limit absorption. |
| C9784 | Gastric restrictive procedure, endoscopic sleeve gastroplasty... (code terminated effective 01/01/26). |
| C9785 | Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components. |
| 43846 | Open gastric bypass (short limb ≤150 cm) — restrictive and malabsorptive component |
| 43644 | Laparoscopic gastric bypass |
| 43770 | Laparoscopic adjustable gastric banding |
| 43847 | Biliopancreatic diversion (Scopinaro procedure) / long-limb gastric bypass (used for variations) |
| 43842 | Vertical-banded gastroplasty (VBG) |
| 43645 | Laparoscopic malabsorptive procedure (non-specific) |
| 43843 | Gastric restrictive procedure, without gastric bypass, other than VBG (commonly used for gastric plication) |
| 43999 | Unlisted procedure, stomach (used for single anastomosis duodeno-ileal bypass with sleeve gastrectomy) |
| 43999 | Unlisted procedure, stomach; used for SADI-S because no specific CPT code exists |
| Spatz3 Adjustable Balloon | PMA-approved intragastric adjustable balloon (max placement 8 months) |
| Obalon intragastric balloon | PMA-approved intragastric balloon (BMI 30–40; max placement 6 months) |
| AspireAssist System | PMA-approved aspiration device for long-term use in obese adults >22 years (BMI 35–55) |
| ORBERA intragastric balloon | PMA-approved intragastric balloon (BMI 30–40; max placement 6 months) |
| LAP-BAND Adjustable Gastric Band | PMA-approved adjustable gastric band (indicated for severe obesity per labeling) |
| REALIZE Adjustable Gastric Band | PMA-approved adjustable gastric band (indicated for morbidly obese adults per labeling) |
| Medicare NCD list | RYGB, LAGB, BPD/DS considered reasonable and necessary for Medicare beneficiaries with BMI >35 plus comorbidity; open and laparoscopic sleeve gastrectomy and open adjustable gastric banding listed as noncovered for Medicare |
| C9784 | HCPCS code added previously; noted terminated effective January 1, 2026 |
| C9785 | HCPCS code added July 1, 2023 |
| 0312T | CPT code previously included; removed effective 01/01/23 and term dated in coding section |
| 0313T | CPT code previously included; removed effective 01/01/23 and term dated in coding section |
| 0314T | CPT code previously included; removed effective 01/01/23 and term dated in coding section |
| 0315T | CPT code previously included; removed effective 01/01/23 and term dated in coding section |
| 0316T | CPT code previously included; removed effective 01/01/23 and term dated in coding section |
| 0317T | CPT code previously included; removed effective 01/01/23 and term dated in coding section |
| 43290 | New CPT code added |
| 43291 | New CPT code added |
Prior Authorization, Documentation, and Operational Notes
Prior authorization required
Obtain prior authorization before bariatric procedures; the request must demonstrate that medical necessity criteria are met (BMI meeting policy thresholds, relevant comorbidities, completion of required preoperative evaluations, and mental health clearance).
- Prior authorization is required for listed bariatric procedures and associated CPT/HCPCS codes.
- Authorization requests must document medical necessity per policy criteria.
Required supporting documentation for authorization
Include complete supporting documentation with the prior authorization: calculated BMI (with Asian-specific thresholds when applicable), documentation of obesity-related comorbidities, evidence of participation in a physician‑administered weight‑loss program (≥3 continuous months within 12 months pre‑op), and mental health evaluation and clearance by a licensed mental health provider (a surgeon summary letter alone is insufficient).
- Record member weight and BMI calculation (see BMI calculation guidance).
- Document program name, dates, and evidence of active participation (weight, diet, exercise).
- Provide licensed mental health provider evaluation and clearance; a provider summary letter alone does not meet this requirement.
Use applicable procedure codes on authorization
Reference the applicable CPT/HCPCS codes on authorization requests and claims for the specific bariatric procedure being requested; include unlisted code details when applicable and ensure coding matches the planned technique (open vs laparoscopic) and procedure type.
Unlisted coding for SADI‑S (use 43999)
For SADI‑S (single anastomosis duodeno‑ileal bypass with sleeve gastrectomy) use unlisted stomach procedure code 43999 for prior authorization and claims because there is no specific CPT code for this procedure.
- Include a detailed operative description and rationale when submitting 43999 for SADI‑S.
- Attach intraoperative or surgeon documentation to support use of an unlisted code for clinical review.
Document BMI and comorbidities for prior auth
Provide BMI and comorbidity documentation in the authorization request: cite relevant BMI threshold (e.g., BMI ≥40, BMI 35–39.9 with an obesity‑related comorbidity, or BMI 30–34.9 with inadequately controlled T2D) and list documented obesity‑related conditions that support coverage.
- Document diabetes control (e.g., HbA1c ≥7) when claiming T2D indication.
- Clearly indicate which policy BMI threshold is being met (including Asian‑specific thresholds when applicable).
Verify FDA‑labeled device indications for device authorizations
Confirm device labeling and FDA‑approved indications for implantable bariatric devices when requesting authorization; verify device‑specific eligibility criteria and labeled time limits (e.g., intragastric balloon placement duration and BMI ranges).
- Match member's BMI and comorbidity profile to device labeled indications (e.g., ORBERA, Spatz3, AspireAssist, LAP‑BAND, REALIZE).
- Note device‑specific maximum placement durations (e.g., 6–8 months for certain balloons) in the request.
Guidelines do not replace payer authorization
Do not rely on cited professional guideline references alone to determine payer authorization rules; guidelines inform expectations but the policy does not substitute for obtaining company prior authorization per member benefits.
- Guideline citations (ASMBS, IFSO, ASGE, etc.) inform clinical expectations but do not define payer-specific prior authorization workflows.
- Providers must request authorization per the health plan's processes and benefit terms.
Obtain pre‑procedure authorization per plan rules
Obtain authorization prior to the procedure per member benefit requirements; this policy serves as guidance for Company staff but providers must secure pre‑procedure authorization when required by the plan.
- Authorization is implied by the policy as the basis for Company coverage determinations.
- Verify whether the member's plan requires preauthorization and obtain it accordingly.
Document failed conservative therapy (3‑month program)
Document participation in and failure of conservative measures before surgery: physician‑administered weight‑reduction program of at least three continuous months (within 12 months before surgery) is expected, and for OSA document trial and failure of CPAP/BiPAP or oral appliances when applicable.
- Evidence of active participation should include weight records, named dietary program, and exercise regimen.
- For OSA, document polysomnography and definition of CPAP/BiPAP failure (residual AHI ≥15 or inability to tolerate therapy).
Document failed medical weight‑loss attempts
Before considering surgery, show documentation of failed conservative weight‑loss measures (medical weight loss attempts); some centers may require active participation in a formal supervised program with frequent documentation of weight, diet, and exercise.
- Include records from structured programs (e.g., Weight Watchers, Jenny Craig) with provider supervision if used.
- Provide dates and duration of the supervised program within the 12‑month preoperative window.
Expect documented dietary/lifestyle interventions prior to surgery
Convey that dietary and lifestyle interventions are expected before surgery and that bariatric procedures are considered when these conservative measures have failed to achieve needed weight loss.
- Document prior non‑surgical management attempts and rationale for proceeding to surgery.
- Ensure conservative therapy efforts are summarized in the medical record submitted for review.
Specify indication tier by BMI and comorbidity
Indicate which BMI/comorbidity tier supports the request: class III (BMI ≥40), class II (BMI 35–39.9) with at least one severe obesity‑related comorbidity, or class I (BMI 30–34.9) with inadequately controlled T2D despite optimal therapy.
- State the specific comorbidity(ies) qualifying the request (e.g., uncontrolled T2D, OSA, NAFLD).
- If the member is Asian, use adjusted BMI thresholds per policy.
Document consideration/role of non‑surgical or short‑term therapies
When considering non‑surgical or short‑term procedural options (e.g., intragastric balloons), document that these therapies were considered or tried as per guideline context and whether short‑term adjunctive approaches are appropriate to the member's goals.
- Note that intragastric balloons may be considered for short‑term (~6 months) weight loss alongside lifestyle interventions.
- If an endoscopic therapy is planned, include documentation of guideline‑based candidacy and monitoring plans.
Include safety monitoring plan for intragastric balloons
For intragastric balloons, include counseling and monitoring plans in the authorization and medical record because FDA safety communications recommend close monitoring and patient counseling regarding potential serious adverse events (e.g., hyperinflation, pancreatitis, obstruction, premature removal).
- Document patient counseling on symptoms of life‑threatening complications and a monitoring plan for the duration of balloon treatment.
- Confirm device brand and labeled maximum placement time in the request.
No specific step‑therapy requirements stated
No formal step‑therapy protocol is specified in the references; do not assume a payer step‑therapy sequence beyond the policy's expectation of documented conservative management and program participation.
- References summarize guideline approaches but do not define explicit payer step‑therapy requirements.
- Authorization decisions are based on documented failure of conservative measures, not a specified step sequence in these references.
Provide supervised program participation dates and evidence
When documenting program participation history, provide dates and duration of supervised weight‑reduction participation; historically requirements changed from six to three months, so supply current documentation of at least three continuous months (90 days) within 12 months pre‑op.
- State program start and end dates and the supervising provider or program name.
- Include weight trend data during the program to show active participation.
Required preoperative documentation for review
Ensure medical records submitted for authorization include BMI calculation (with Asian‑specific thresholds when applicable), documented comorbid conditions, completion details of a physician‑administered weight‑loss program of ≥3 consecutive months within 12 months pre‑op, and mental health evaluation and clearance by a licensed mental health provider.
- Include BMI calculation method and source data (weight, height, dates).
- Provide documentation of program content, duration, and active participation.
Include program details and weight data in records
When submitting preoperative documentation, include program details (name of program or supervising clinician), specific weight measurements and dates, and calculation of weight‑loss metrics when relevant (percent EWL, percent TWL).
- Attach program notes showing member weight at program start and end, dietary plan, and exercise regimen.
- Provide EWL and TWL calculations using provided formulas when applicable.
Provide BMI and weight‑loss calculations
Include BMI calculations and, when relevant, weight‑loss calculations such as percent excess weight loss (EWL) and percent total weight loss (TWL) in the medical record submitted for authorization or utilization review.
- Use the policy's BMI calculation guidance and the provided formulas for EWL and TWL.
- Document preoperative and most recent weights with dates to permit calculation.
Document EGD indication, findings, and impact on planning
If a preoperative EGD is performed, document the indication (symptoms vs surgeon discretion), findings, and how findings affected management or operative planning; use high‑quality visualization and standard classifications when available.
- Record whether EGD was performed for symptoms or at surgeon discretion and summarize findings (e.g., large hiatal hernia, peptic ulcer, H. pylori).
- Document any operative changes or delays resulting from EGD findings.
Document comprehensive preoperative evaluation
Perform and document a comprehensive preoperative evaluation for weight‑related complications and causes of obesity per guideline recommendations; record factors that affect the recommendation for surgery (medical, psychosocial, developmental for adolescents).
- Include assessment of comorbid conditions and how surgery is expected to address them.
- For adolescents, include multidisciplinary evaluation and developmental/readiness documentation.
Include society‑recommended preoperative evaluation elements
Follow society‑recommended pre‑operative evaluation components in documentation: weight‑related complication assessment, causes of obesity, psychosocial and developmental factors (for adolescents), and factors that affect operative suitability.
- Cite relevant guideline recommendations used to support clinical decisions in the record.
- Provide documentation of multidisciplinary input when required.
Justify and document preoperative EGD indication and technique
When EGD is performed preoperatively, document the indication carefully since routine EGD identifies management‑changing findings in only about 20% of patients; justify routine versus symptom‑guided EGD and record findings using high‑quality technique and established classifications.
- If routine EGD is performed at surgeon discretion, state the rationale and any findings that altered care.
- Ensure endoscopy reports document high‑definition visualization and standard terminology per AGA guidance.
Reference guideline documents to support documentation
Cite relevant professional guideline documents (ASMBS, AACE/ACE, AGA, ASGE, VA/DoD, AAP, etc.) in the clinical record to support documentation expectations and preoperative planning when applicable.
- Include guideline references used to inform the preoperative plan when they support the medical necessity rationale.
- Do not substitute guideline citation for the required documentation items described in policy.
Confirm member benefits and plan limitations
Verify member benefit limitations and preauthorization requirements with the member's benefit booklet or customer service prior to submission; coverage is subject to plan limits and conditions and this policy does not apply to Medicare Advantage.
- Confirm whether the member's plan includes coverage for bariatric procedures and any age or benefit limits.
- Contact customer service or consult the benefit booklet to confirm authorization workflow and plan‑specific limits.
Do not request coverage for investigational/not‑necessary procedures
Avoid requesting coverage for procedures listed as investigational or not medically necessary (e.g., vertical‑banded gastroplasty, long‑limb gastric bypass >150 cm, endoscopic primary bariatric procedures, intragastric balloons and certain endoscopic revision procedures) as these are triggers for denial.
- Do not submit authorization requests for explicitly investigational or not medically necessary procedures per policy.
- If a procedure is investigational, provide alternative, evidence‑based treatment plan and rationale.
Include licensed mental health evaluation and clearance
Include a licensed mental health provider evaluation and clearance in the preoperative record; absence of documented mental health assessment and clearance (a provider summary letter alone is insufficient) may trigger denial.
- Mental health evaluation must rule out contraindicating disorders, inability to consent, or inability to comply with perioperative requirements.
- Do not rely on surgeon summary letters alone to satisfy this requirement.
Risk of denial for missing conservative management documentation
Failure to document participation in and active engagement with a structured weight‑loss program (including weight records, dietary program name, and exercise documentation) or lack of documented failure of conservative measures may result in denial of surgical approval.
- Provide objective evidence of program participation and failure to achieve adequate weight loss with conservative therapy.
- If structured programs were used, include supervising provider documentation.
EGD indication must be documented when performed
If preoperative EGD is performed, document the appropriate indication; failure to document a legitimate indication (symptoms or justified surgeon discretion) and associated findings may prompt utilization review or denial.
- State whether EGD was symptom‑driven or performed at surgeon discretion and summarize findings and their effect on management.
- Ensure endoscopy reports use standard classifications and adequate visualization techniques.
Routine preoperative EGD may be scrutinized
Note that routine preoperative EGD changes operative management in only about 20% of cases; when EGD is submitted as routine rather than symptom‑indicated, reviewers may scrutinize its justification and this could affect authorization outcomes.
- If ordering routine EGD, include rationale for surgeon discretion and any prior symptoms or risk factors prompting the test.
- Attach the EGD report and explain any management changes resulting from findings.
Document absence of contraindications (or address them)
Screen for and document contraindications that could preclude surgery (e.g., medically correctable causes of obesity, untreated or poorly controlled substance abuse, pregnancy/planned pregnancy, active eating disorder, or inability to adhere to postoperative requirements), as their presence may trigger denial.
- Document treatment or resolution of any medically correctable cause of obesity before proceeding.
- If contraindications exist, include plans for management or stabilization prior to reconsideration.
Medicare noncoverage may trigger denial for listed procedures
Be aware Medicare NCD noncoverage listings when authorizing for Medicare beneficiaries: certain procedures (open and laparoscopic sleeve gastrectomy, open adjustable gastric banding, vertical banded gastroplasty) are listed as noncovered for Medicare and may lead to denial under Medicare rules.
- For Medicare patients, verify NCD applicability and do not expect Medicare coverage for procedures listed as noncovered in the NCD.
- If treating a Medicare beneficiary, include NCD‑supported procedures and ensure documentation aligns with Medicare criteria.
Follow payer operational authorization process (not defined in references)
References and guideline sections do not state operational prior authorization workflows; providers must follow the payer's operational authorization processes and submit the documentation required by the plan.
- The policy cites guidelines but does not provide plan‑specific operational steps for authorization.
- Contact the payer or use the payer's portal/process to submit required documents.
Benefit limitations can cause denial—verify plan specifics
Coverage decisions are subject to member benefit limits; verify plan‑specific limitations (age, number of procedures, device coverage) prior to submitting an authorization because benefit limits can cause denial.
- Confirm whether the member's plan excludes certain procedures or devices.
- If benefit limitations apply, document that the requested service is within plan allowances.
Background and Clinical Context
Bariatric surgery is used to treat clinically severe obesity and related complications. The policy frames surgery as appropriate for carefully selected patients who have failed conservative management and who meet specified BMI and comorbidity thresholds. Expected outcomes include substantial and sustained weight loss and improvement or remission of obesity-related comorbidities when performed at accredited centers by experienced surgeons; procedure type and patient selection should be individualized to balance benefits and risks.
Definitions and Key Terms
Policy Revision History
Policy added to Surgery Section as a new policy (initial adoption).
Policy updated to include expanded discussion of biliopancreatic bypass and gastric banding; policy statement unchanged.
Policy revised to include mini-gastric bypass.
Policy revised to include LAP-BAND gastric restrictive procedure as medically necessary (replaced CP.MP.BC.7.01.47).
Policy updated after literature search; policy statement expanded to indicate liver biopsy during morbid obesity surgery as not medically necessary.
Interim review approved October 10, 2022; endoscopic procedures (TORe, ROSE) listed as investigational and minor edits/formatting changes made; wording standardized from 'patient' to 'individual'.
Annual review updated policy with literature through January 3, 2023 and added medically necessary indication for individuals with T2 diabetes and class I obesity.
Coding update added HCPCS codes C9784 and C9785.
Policy last revised and reviewed with effective date set to 2026-08-01 reflecting current consolidated updates and administrative refinements.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.